- Volume is elevated versus the 13-week average, confirming attention.
000710
SHZ
Week ended 07 Aug 2026
Weekly Investor Report
Berry Genomics Co.,Ltd · Healthcare · Diagnostics & Research
Latest close
9.08 CNY
6.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 6.8%, after a 16.0% four-week move. The latest news-sentiment score is 50/100.
Setup score
38
out of 100
Latest Close
9.08 CNY
7 Aug 2026
1W Return
6.8%
latest completed week
4W Return
16.0%
short-term follow-through
12W Return
-12.8%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
3.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.8%
Latest completed week; four-week move 16.0%.
Indicator stack
7/54
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 6.8%, after a 16.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 16.0% over four weeks, -12.8% over 12 weeks, and -38.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.16Latest activity-pressure read.
Pressure change88.0%Four-week change in activity pressure.
Leadership-23.60Latest relative-leadership reading.
RS change42.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.7%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+12.1%Week of 31 Jul.
Worst week-8.9%Week of 22 May.
Latest week+6.8%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains4
Flat weeks0
Modest losses10
Sharp losses7
Recent vol6.3%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Diagnostics & Research
4-week rank5 / 19
Group average10.5%
Trend breadth10.5%
Trend10.5%active weekly trend signals
MD42.1%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Enterprise value to revenue forward of Berry Genomics Co. Ltd. Class A – SZSE:000710 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 9.08 CNY | 6.8% | 10.09 CNY | 10.68 CNY | -0.16 | -23.60 | 164.0M | Off |
| 31 Jul 2026 | 8.50 CNY | 12.1% | 10.16 CNY | 10.69 CNY | -0.64 | -25.83 | 54.6M | Off |
| 24 Jul 2026 | 7.58 CNY | -3.3% | 10.26 CNY | 10.71 CNY | -0.99 | -35.74 | 41.5M | Off |
| 17 Jul 2026 | 7.84 CNY | 0.1% | 10.39 CNY | 10.73 CNY | -1.16 | -34.33 | 63.2M | Off |
| 10 Jul 2026 | 7.83 CNY | -2.5% | 10.51 CNY | 10.75 CNY | -1.36 | -41.30 | 71.8M | Off |
| 3 Jul 2026 | 8.03 CNY | 9.0% | 10.63 CNY | 10.77 CNY | -1.58 | -43.01 | 8.3M | Off |
| 26 Jun 2026 | 7.37 CNY | -6.2% | 10.77 CNY | 10.80 CNY | -1.68 | -49.15 | 7.3M | Off |
| 19 Jun 2026 | 7.86 CNY | -2.5% | 10.91 CNY | 10.82 CNY | -1.62 | -47.49 | 25.8M | Off |
| 12 Jun 2026 | 8.06 CNY | -3.1% | 11.11 CNY | 10.85 CNY | -1.46 | -43.28 | 6.0M | Off |
| 5 Jun 2026 | 8.32 CNY | -5.7% | 11.29 CNY | 10.87 CNY | -1.06 | -43.78 | 7.3M | Off |
| 29 May 2026 | 8.82 CNY | -7.0% | 11.45 CNY | 10.90 CNY | -0.81 | -42.45 | 42.2M | Off |
| 22 May 2026 | 9.48 CNY | -8.9% | 11.59 CNY | 10.92 CNY | -0.84 | -39.18 | 59.9M | Off |
| 15 May 2026 | 10.41 CNY | -5.3% | 11.69 CNY | 10.94 CNY | -0.97 | -34.05 | 108.3M | Off |
| 8 May 2026 | 10.99 CNY | 10.0% | 11.78 CNY | 10.96 CNY | -1.27 | -31.13 | 33.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.